Cargando…
Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan
BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187657/ https://www.ncbi.nlm.nih.gov/pubmed/37201126 http://dx.doi.org/10.2147/IDR.S406253 |
_version_ | 1785042777050972160 |
---|---|
author | Jabeen, Kokab Saleem, Sidrah Jahan, Shah Nizamudin, Summiya Arshad, Faiqa Huma, Zill-e Raza, Syed Mohsin Mehmood, Maria Roman, Muhammad Haq, Faiz Ul |
author_facet | Jabeen, Kokab Saleem, Sidrah Jahan, Shah Nizamudin, Summiya Arshad, Faiqa Huma, Zill-e Raza, Syed Mohsin Mehmood, Maria Roman, Muhammad Haq, Faiz Ul |
author_sort | Jabeen, Kokab |
collection | PubMed |
description | BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the arsenal. The current empiric choice is azithromycin which is vulnerable to resistance too. This study aimed to assess the burden of XDR typhoid and the frequency of resistance determinants in blood culture samples collected from different hospitals in Lahore, Pakistan. METHODS: A total of 835 blood cultures were collected from different tertiary care hospitals in Lahore during January 2019 to December 2021. Among 835 blood cultures, 389 Salmonella Typhi were identified, and 150 were XDR S. Typhi (resistant to all recommended antibiotics). Antibiotics resistance genes of the first-line drugs (bla(TEM-1), catA1, sul1, and dhfR7) and second line drugs (gyrB, gyrA, qnrS, ParC and ParE) were investigated among XDR S. Typhi. There were different CTX-M genes isolated using the specific primers, bla(CTX-M-U), bla(CTX-M-1,) bla(CTX-M-15,) bla(CTX-M-2,) bla(CTX-M-8) and bla(CTX-M-9). RESULTS: Antibiotic resistant genes of the first-line drugs were isolated with different frequency, bla(TEM-1) (72.6%), catA1 (86.6%), sul1 (70%), and dhfR7 (56%). Antibiotics resistance genes of second-line drugs were isolated as: gyrB (60%), gyrA (49.3%), qnrS (32.6%), parC (44%) and parE (28%). Among CTX-M genes, bla(CTX-M-U) (63.3%) was the most frequent followed by bla(CTX-M-15) (39.3%) and bla(CTX-M-1) (26%). CONCLUSION: Our study concluded that XDR isolates circulating in Pakistan have acquired first-line and second-line antibiotic resistant genes quite successfully along with CTX-M genes (ESBLs) rendering them resistant to the third generation cephalosporins as well. Emergence of azithromycin resistance in XDR S. Typhi which is currently used as an empiric treatment option is worrisome and needs to be monitored carefully in endemic countries like Pakistan. |
format | Online Article Text |
id | pubmed-10187657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-101876572023-05-17 Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan Jabeen, Kokab Saleem, Sidrah Jahan, Shah Nizamudin, Summiya Arshad, Faiqa Huma, Zill-e Raza, Syed Mohsin Mehmood, Maria Roman, Muhammad Haq, Faiz Ul Infect Drug Resist Original Research BACKGROUND: The emergence of extensively drug-resistant (XDR) typhoid in Pakistan has endangered the treatment options available to manage this infection. Third generation cephalosporin were the empiric choice to treat typhoid fever in Pakistan, but acquisition of ESBLs have knocked them out of the arsenal. The current empiric choice is azithromycin which is vulnerable to resistance too. This study aimed to assess the burden of XDR typhoid and the frequency of resistance determinants in blood culture samples collected from different hospitals in Lahore, Pakistan. METHODS: A total of 835 blood cultures were collected from different tertiary care hospitals in Lahore during January 2019 to December 2021. Among 835 blood cultures, 389 Salmonella Typhi were identified, and 150 were XDR S. Typhi (resistant to all recommended antibiotics). Antibiotics resistance genes of the first-line drugs (bla(TEM-1), catA1, sul1, and dhfR7) and second line drugs (gyrB, gyrA, qnrS, ParC and ParE) were investigated among XDR S. Typhi. There were different CTX-M genes isolated using the specific primers, bla(CTX-M-U), bla(CTX-M-1,) bla(CTX-M-15,) bla(CTX-M-2,) bla(CTX-M-8) and bla(CTX-M-9). RESULTS: Antibiotic resistant genes of the first-line drugs were isolated with different frequency, bla(TEM-1) (72.6%), catA1 (86.6%), sul1 (70%), and dhfR7 (56%). Antibiotics resistance genes of second-line drugs were isolated as: gyrB (60%), gyrA (49.3%), qnrS (32.6%), parC (44%) and parE (28%). Among CTX-M genes, bla(CTX-M-U) (63.3%) was the most frequent followed by bla(CTX-M-15) (39.3%) and bla(CTX-M-1) (26%). CONCLUSION: Our study concluded that XDR isolates circulating in Pakistan have acquired first-line and second-line antibiotic resistant genes quite successfully along with CTX-M genes (ESBLs) rendering them resistant to the third generation cephalosporins as well. Emergence of azithromycin resistance in XDR S. Typhi which is currently used as an empiric treatment option is worrisome and needs to be monitored carefully in endemic countries like Pakistan. Dove 2023-05-12 /pmc/articles/PMC10187657/ /pubmed/37201126 http://dx.doi.org/10.2147/IDR.S406253 Text en © 2023 Jabeen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Jabeen, Kokab Saleem, Sidrah Jahan, Shah Nizamudin, Summiya Arshad, Faiqa Huma, Zill-e Raza, Syed Mohsin Mehmood, Maria Roman, Muhammad Haq, Faiz Ul Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title | Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title_full | Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title_fullStr | Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title_full_unstemmed | Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title_short | Molecular Characterization of Extensively Drug Resistant Salmonella Enterica Serovar Typhi Clinical Isolates from Lahore, Pakistan |
title_sort | molecular characterization of extensively drug resistant salmonella enterica serovar typhi clinical isolates from lahore, pakistan |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187657/ https://www.ncbi.nlm.nih.gov/pubmed/37201126 http://dx.doi.org/10.2147/IDR.S406253 |
work_keys_str_mv | AT jabeenkokab molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT saleemsidrah molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT jahanshah molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT nizamudinsummiya molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT arshadfaiqa molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT humazille molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT razasyedmohsin molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT mehmoodmaria molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT romanmuhammad molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan AT haqfaizul molecularcharacterizationofextensivelydrugresistantsalmonellaentericaserovartyphiclinicalisolatesfromlahorepakistan |